4//SEC Filing
Nabulsi Azmi 4
Accession 0000950170-24-067539
CIK 0001783183other
Filed
May 30, 8:00 PM ET
Accepted
May 31, 6:34 PM ET
Size
6.4 KB
Accession
0000950170-24-067539
Insider Transaction Report
Form 4
Nabulsi Azmi
Chief Operating Officer
Transactions
- Award
Common Stoock
2024-05-31+7,500→ 249,567 total
Holdings
- 785,700(indirect: By Trust)
Common Stock
- 3,578.93(indirect: By 401(k))
Common Stock
Footnotes (1)
- [F1]Represents restricted stock units ("RSUs") granted on May 31, 2024. One third (1/3) of the total number of RSUs granted vest on each of the first three anniversaries of December 18, 2023, the vesting commencement date, subject to the Reporting Person's continued service on the applicable vesting date. Each RSU represents a contingent right to receive one share of common stock of the Issuer.
Documents
Issuer
Phathom Pharmaceuticals, Inc.
CIK 0001783183
Entity typeother
Related Parties
1- filerCIK 0001791412
Filing Metadata
- Form type
- 4
- Filed
- May 30, 8:00 PM ET
- Accepted
- May 31, 6:34 PM ET
- Size
- 6.4 KB